Wang Y, Kanneganti TD. From pyroptosis, apoptosis and necroptosis to PANoptosis: a mechanistic compendium of programmed cell death pathways. Comput Struct Biotechnol J. 2021;19:4641–57.
Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007;35:495–516.
Li Y, Jiang Q. Uncoupled pyroptosis and IL-1beta secretion downstream of inflammasome signaling. Front Immunol. 2023;14:1128358.
Dhuriya YK, Sharma D. Necroptosis: a regulated inflammatory mode of cell death. J Neuroinflamm. 2018;15:199.
Gao J, Xiong A, Liu J, Li X, Wang J, Zhang L, et al. PANoptosis: bridging apoptosis, pyroptosis, and necroptosis in cancer progression and treatment. Cancer Gene Ther. 2024;31:970–83.
He X, Jiang X, Guo J, Sun H, Yang J. PANoptosis in bacterial infections: a double-edged sword balancing host immunity and pathogenesis. Pathogens. 2025;14:43.
Muzes G, Sipos F. PANoptosis as a two-edged sword in colorectal cancer: a pathogenic mechanism and therapeutic opportunity. Cells. 2025;14:730.
Jiang Z, Wang J, Dao C, Zhu M, Li Y, Liu F, et al. Utilizing a novel model of PANoptosis-related genes for enhanced prognosis and immune status prediction in kidney renal clear cell carcinoma. Apoptosis. 2024;29:681–92.
Meng X, Song Q, Liu Z, Liu X, Wang Y, Liu J. Neurotoxic beta-amyloid oligomers cause mitochondrial dysfunction-the trigger for PANoptosis in neurons. Front Aging Neurosci. 2024;16:1400544.
Wu J, Guo Z, Wang L, Shen Y, Li X, Zhang Z, et al. Porphyromonas gingivalis induces Zbp1-mediated macrophages PANoptosis in periodonitis pathophysiology. Exp Mol Med. 2025;57:964–78.
Maruzuru Y, Koyanagi N, Kato A, Kawaguchi Y. Role of the DNA binding activity of herpes simplex virus 1 VP22 in evading AIM2-dependent inflammasome activation induced by the virus. J Virol. 2021;95:e02172–20.
Molina-Lopez C, Hurtado-Navarro L, Garcia CJ, Angosto-Bazarra D, Vallejo F, Tapia-Abellan A, et al. Pathogenic NLRP3 mutants form constitutively active inflammasomes resulting in immune-metabolic limitation of IL-1beta production. Nat Commun. 2024;15:1096.
Chae JJ, Cho YH, Lee GS, Cheng J, Liu PP, Feigenbaum L, et al. Gain-of-function Pyrin mutations induce NLRP3 protein-independent interleukin-1beta activation and severe autoinflammation in mice. Immunity. 2011;34:755–68.
Meng Y, Horne CR, Samson AL, Dagley LF, Young SN, Sandow JJ, et al. Human RIPK3 C-lobe phosphorylation is essential for necroptotic signaling. Cell Death Dis. 2022;13:565.
Wan N, Shi J, Xu J, Huang J, Gan D, Tang M, et al. Gasdermin D: a potential new auxiliary pan-biomarker for the detection and diagnosis of diseases. Biomolecules. 2023;13:1664.
Vucur M, Roderburg C, Kaiser L, Schneider AT, Roy S, Loosen SH, et al. Elevated serum levels of mixed lineage kinase domain-like protein predict survival of patients during intensive care unit treatment. Dis Markers. 2018;2018:1983421.
Karki R, Sundaram B, Sharma BR, Lee S, Malireddi RKS, Nguyen LN, et al. ADAR1 restricts ZBP1-mediated immune response and PANoptosis to promote tumorigenesis. Cell Rep. 2021;37:109858.
Mishra S, Jain D, Dey AA, Nagaraja S, Srivastava M, Khatun O, et al. Bat RNA viruses employ viral RHIMs orchestrating species-specific cell death programs linked to Z-RNA sensing and ZBP1-RIPK3 signaling. iScience. 2024;27:111444.
Malireddi RKS, Sharma BR, Bynigeri RR, Wang Y, Lu J, Kanneganti TD. ZBP1 drives IAV-induced NLRP3 inflammasome activation and lytic cell death, PANoptosis, independent of the necroptosis executioner MLKL. Viruses. 2023;15:2141.
Kuriakose T, Man SM, Malireddi RK, Karki R, Kesavardhana S, Place DE, et al. ZBP1/DAI is an innate sensor of influenza virus triggering the NLRP3 inflammasome and programmed cell death pathways. Sci Immunol. 2016;1:aag2045.
Upton JW, Kaiser WJ, Mocarski ES. DAI/ZBP1/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA. Cell Host Microbe. 2012;11:290–7.
Jones JW, Kayagaki N, Broz P, Henry T, Newton K, O’Rourke K, et al. Absent in melanoma 2 is required for innate immune recognition of Francisella tularensis. Proc Natl Acad Sci USA. 2010;107:9771–6.
Zhu Q, Zheng M, Balakrishnan A, Karki R, Kanneganti TD. Gasdermin D promotes AIM2 inflammasome activation and is required for host protection against Francisella novicida. J Immunol. 2018;201:3662–8.
Lee S, Karki R, Wang Y, Nguyen LN, Kalathur RC, Kanneganti TD. AIM2 forms a complex with pyrin and ZBP1 to drive PANoptosis and host defence. Nature. 2021;597:415–9.
Lammert CR, Frost EL, Bellinger CE, Bolte AC, McKee CA, Hurt ME, et al. AIM2 inflammasome surveillance of DNA damage shapes neurodevelopment. Nature. 2020;580:647–52.
Hou Y, He H, Ma M, Zhou R. Apilimod activates the NLRP3 inflammasome through lysosome-mediated mitochondrial damage. Front Immunol. 2023;14:1128700.
Xu H, Yang J, Gao W, Li L, Li P, Zhang L, et al. Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome. Nature. 2014;513:237–41.
Oh S, Lee J, Oh J, Yu G, Ryu H, Kim D, et al. Integrated NLRP3, AIM2, NLRC4, Pyrin inflammasome activation and assembly drive PANoptosis. Cell Mol Immunol. 2023;20:1513–26.
de Torre-Minguela C, Mesa Del Castillo P, Pelegrin P. The NLRP3 and Pyrin inflammasomes: implications in the pathophysiology of autoinflammatory diseases. Front Immunol. 2017;8:43.
Upmanyu K, Upadhyay S. Wiring and rewiring PANoptosis: molecular vulnerabilities for targeting inflammatory cell death in human disease. Cytokine Growth Factor Rev. 2025;86:1–16.
Chhatbar C, Schulz M, Sankowski R. Innate immune sensing of danger signals: novel mechanism of heme complex-mediated lytic cell death. Signal Transduct Target Ther. 2024;9:259.
Compan V, Martin-Sanchez F, Baroja-Mazo A, Lopez-Castejon G, Gomez AI, Verkhratsky A, et al. Apoptosis-associated speck-like protein containing a CARD forms specks but does not activate caspase-1 in the absence of NLRP3 during macrophage swelling. J Immunol. 2015;194:1261–73.
Kumar SP, Nadendla EK, Malireddi RKS, Haque SA, Mall R, Neuwald AF, et al. Evolutionary and functional analysis of Caspase-8 and ASC interactions to drive lytic cell death, PANoptosis. Mol Biol Evol. 2025;42:msaf096.
Liu Y, Zhai H, Alemayehu H, Boulanger J, Hopkins LJ, Borgeaud AC, et al. Cryo-electron tomography of NLRP3-activated ASC complexes reveals organelle co-localization. Nat Commun. 2023;14:7246.
Tzeng TC, Schattgen S, Monks B, Wang D, Cerny A, Latz E, et al. A fluorescent reporter mouse for inflammasome assembly demonstrates an important role for cell-bound and free ASC specks during in vivo infection. Cell Rep. 2016;16:571–82.
Tu H, Xiong W, Zhang J, Zhao X, Lin X. Tyrosine phosphorylation regulates RIPK1 activity to limit cell death and inflammation. Nat Commun. 2022;13:6603.
Koerner L, Wachsmuth L, Kumari S, Schwarzer R, Wagner T, Jiao H, et al. ZBP1 causes inflammation by inducing RIPK3-mediated necroptosis and RIPK1 kinase activity-independent apoptosis. Cell Death Differ. 2024;31:938–53.
Schorn F, Werthenbach JP, Hoffmann M, Daoud M, Stachelscheid J, Schiffmann LM, et al. cIAPs control RIPK1 kinase activity-dependent and -independent cell death and tissue inflammation. EMBO J. 2023;42:e113614.
Ranjan K, Pathak C. Cellular dynamics of Fas-associated death domain in the regulation of cancer and inflammation. Int J Mol Sci. 2024;25:3228.
Rodriguez DA, Tummers B, Shaw JJP, Quarato G, Weinlich R, Cripps J, et al. The interaction between RIPK1 and FADD controls perinatal lethality and inflammation. Cell Rep. 2024;43:114335.
Russo HM, Rathkey J, Boyd-Tressler A, Katsnelson MA, Abbott DW, Dubyak GR. Active caspase-1 induces plasma membrane pores that precede pyroptotic lysis and are blocked by lanthanides. J Immunol. 2016;197:1353–67.
Salvesen GS, Walsh CM. Functions of caspase 8: the identified and the mysterious. Semin Immunol. 2014;26:246–52.
Sarhan J, Liu BC, Muendlein HI, Li P, Nilson R, Tang AY, et al. Caspase-8 induces cleavage of gasdermin D to elicit pyroptosis during Yersinia infection. Proc Natl Acad Sci USA. 2018;115:E10888–E97.
Conos SA, Chen KW, De Nardo D, Hara H, Whitehead L, Nunez G, et al. Active MLKL triggers the NLRP3 inflammasome in a cell-intrinsic manner. Proc Natl Acad Sci USA. 2017;114:E961–E9.
Lawlor KE, Murphy JM, Vince JE. Gasdermin and MLKL necrotic cell death effectors: signaling and diseases. Immunity. 2024;57:429–45.
Yin L, Yuan L, Li J, Jiang B. The liquid-liquid phase separation in programmed cell death. Cell Signal. 2024;120:111215.
Chen H, Huang S, Quan L, Yu C, Zhu Y, Sun X, et al. Liquid‒liquid phase separation: a potentially fundamental mechanism of sepsis. Cell Death Discov. 2025;11:310.
Tran HT, Kratina T, Coutansais A, Michalek D, Hogan BM, Lawlor KE, et al. RIPK3 cleavage is dispensable for necroptosis inhibition but restricts NLRP3 inflammasome activation. Cell Death Differ. 2024;31:662–71.
Dai Z, Liu WC, Chen XY, Wang X, Li JL, Zhang X. Gasdermin D-mediated pyroptosis: mechanisms, diseases, and inhibitors. Front Immunol. 2023;14:1178662.
Zheng M, Kanneganti TD. The regulation of the ZBP1-NLRP3 inflammasome and its implications in pyroptosis, apoptosis, and necroptosis (PANoptosis). Immunol Rev. 2020;297:26–38.
Zhang E, Li X. The emerging roles of pellino family in pattern recognition receptor signaling. Front Immunol. 2022;13:728794.
Wertz IE, O’Rourke KM, Zhou H, Eby M, Aravind L, Seshagiri S, et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature. 2004;430:694–9.
Oh C, Li L, Verma A, Reuven AD, Miao EA, Bliska JB, et al. Neutrophil inflammasomes sense the subcellular delivery route of translocated bacterial effectors and toxins. Cell Rep. 2022;41:111688.
Yang H, Gao J, Zheng Z, Yu Y, Zhang C. Current insights and future directions of LncRNA Morrbid in disease pathogenesis. Heliyon. 2024;10:e36681.
Hu J, Huang S, Liu X, Zhang Y, Wei S, Hu X. miR-155: an important role in inflammation response. J Immunol Res. 2022;2022:7437281.
Baik SH, Ramanujan VK, Becker C, Fett S, Underhill DM, Wolf AJ. Hexokinase dissociation from mitochondria promotes oligomerization of VDAC that facilitates NLRP3 inflammasome assembly and activation. Sci Immunol. 2023;8:eade7652.
Upadhyay S, Khan S, Hassan MI. Exploring the diverse role of pyruvate kinase M2 in cancer: navigating beyond glycolysis and the Warburg effect. Biochim Biophys Acta (BBA) – Rev Cancer. 2024;1879:189089.
Xu L, Ye Y, Gu W, Xu X, Chen N, Zhang L, et al. Histone lactylation stimulated upregulation of PSMD14 alleviates neuron PANoptosis through deubiquitinating PKM2 to activate PINK1-mediated mitophagy after traumatic brain injury. Autophagy. 2025;21:1473–91.
Upadhyay S, Bhardwaj M, Kumar SP, Khan S, Kumar A, Hassan MI. Impact of cancer-associated PKM2 mutations on enzyme activity and allosteric regulation: structural and functional insights into metabolic reprogramming. Biochemistry. 2025;64:1463–75.
Martinez Lagunas K, Savcigil DP, Zrilic M, Carvajal Fraile C, Craxton A, Self E, et al. Cleavage of cFLIP restrains cell death during viral infection and tissue injury and favors tissue repair. Sci Adv. 2023;9:eadg2829.
Kayagaki N, Kornfeld OS, Lee BL, Stowe IB, O’Rourke K, Li Q, et al. NINJ1 mediates plasma membrane rupture during lytic cell death. Nature. 2021;591:131–6.
Kwak MS, Choi S, Kim J, Lee H, Park IH, Oh J, et al. SARS-CoV-2 infection induces HMGB1 secretion through post-translational modification and PANoptosis. Immune Netw. 2023;23:e26.
Liu X, Tang AL, Cheng J, Gao N, Zhang G, Xiao C. RIPK1 in the inflammatory response and sepsis: recent advances, drug discovery and beyond. Front Immunol. 2023;14:1114103.
Peng Y, Zhao H, Yang C, Wang X, Zhang S. PANoptosis in cancer: molecular mechanism, current evidence, and therapeutic implications. J Bio-X Res. 2025;8:0037.
Yang K, Wang X, Pan H, Wang X, Hu Y, Yao Y, et al. The roles of AIM2 in neurodegenerative diseases: insights and therapeutic implications. Front Immunol. 2024;15:1441385.
Zhang T, Yin C, Boyd DF, Quarato G, Ingram JP, Shubina M, et al. Influenza virus Z-RNAs induce ZBP1-mediated necroptosis. Cell. 2020;180:1115–29.e13.
Xu H, Akinyemi IA, Chitre SA, Loeb JC, Lednicky JA, McIntosh MT, et al. SARS-CoV-2 viroporin encoded by ORF3a triggers the NLRP3 inflammatory pathway. Virology. 2022;568:13–22.
Akbal A, Dernst A, Lovotti M, Mangan MSJ, McManus RM, Latz E. How location and cellular signaling combine to activate the NLRP3 inflammasome. Cell Mol Immunol. 2022;19:1201–14.
Kim S, Bauernfeind F, Ablasser A, Hartmann G, Fitzgerald KA, Latz E, et al. Listeria monocytogenes is sensed by the NLRP3 and AIM2 inflammasome. Eur J Immunol. 2010;40:1545–51.
Nguyen LN, Kanneganti TD. PANoptosis in viral infection: the missing puzzle piece in the cell death field. J Mol Biol. 2022;434:167249.
Lin JF, Wang TT, Huang RZ, Tan YT, Chen DL, Ju HQ. PANoptosis in cancer: bridging molecular mechanisms to therapeutic innovations. Cell Mol Immunol. 2025;22:996–1011.
Koo G-B, Morgan MJ, Lee D-G, Kim W-J, Yoon J-H, Koo JS, et al. Methylation-dependent loss of RIP3 expression in cancer represses programmed necrosis in response to chemotherapeutics. Cell Res. 2015;25:707–25.
Koch A, Jeiler B, Roedig J, van Wijk SJL, Dolgikh N, Fulda S. Smac mimetics and TRAIL cooperate to induce MLKL-dependent necroptosis in Burkitt’s lymphoma cell lines. Neoplasia. 2021;23:539–50.
Paik S, Kim JK, Shin HJ, Park E-J, Kim IS, Jo E-K. Updated insights into the molecular networks for NLRP3 inflammasome activation. Cell Mol Immunol. 2025;22:563–96.
Wu MF, Peng X, Zhang MC, Guo H, Xie HT. Ferroptosis and PANoptosis under hypoxia pivoting on the crosstalk between DHODH and GPX4 in corneal epithelium. Free Radic Biol Med. 2025;228:173–82.
Li Y, Du Y, Zhou Y, Chen Q, Luo Z, Ren Y, et al. Iron and copper: critical executioners of ferroptosis, cuproptosis and other forms of cell death. Cell Commun Signal. 2023;21:327.
Lin HC, Chen YJ, Wei YH, Lin HA, Chen CC, Liu TF, et al. Lactic acid fermentation is required for NLRP3 inflammasome activation. Front Immunol. 2021;12:630380.
Tan Y, Chen Q, Li X, Zeng Z, Xiong W, Li G, et al. Pyroptosis: a new paradigm of cell death for fighting against cancer. J Exp Clin Cancer Res. 2021;40:153.
Riebeling T, Kunzendorf U, Krautwald S. The role of RHIM in necroptosis. Biochem Soc Trans. 2022;50:1197–205.
Sharpe AH, Freeman GJ. The B7–CD28 superfamily. Nat Rev Immunol. 2002;2:116–26.
Upadhyay S, Talagayev V, Cho S, Wolber G, Gabr M. Structure-based virtual screening identifies potent CD28 inhibitors that suppress T cell co-stimulation in cellular and mucosal models. Eur J Med Chem. 2025;300:118194.
Upadhyay S, Cho S, Nada H, Gabr MT. Discovery of CD28-targeted small molecule inhibitors of T cell co-stimulation using affinity selection-mass spectrometry (AS-MS) and ex vivo validation. J Med Chem. 2025;68:25112–25.
Li K, Shi H, Zhang B, Ou X, Ma Q, Chen Y, et al. Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer. Signal Transduct Target Ther. 2021;6:362.
Li J, Qu Y. PANoptosis in neurological disorders: mechanisms, implications, and therapeutic potential. Front Immunol. 2025;16:1579360.
Wu PJ, Hung YF, Liu HY, Hsueh YP. Deletion of the inflammasome sensor Aim2 mitigates abeta deposition and microglial activation but increases inflammatory cytokine expression in an alzheimer disease mouse model. Neuroimmunomodulation. 2017;24:29–39.
Duan J, Cao Z, Zhou Z, Huang X, Zhao J, Huang Y, et al. Mitochondrial dysfunction drives ZBP1-mediated PANoptosis to increase the susceptibility of heart failure with preserved ejection fraction-associated atrial fibrillation. J Adv Res. 2025;S2090–1232:00699–X.
Wang WY, Yi WQ, Liu YS, Hu QY, Qian SJ, Liu JT, et al. Z-DNA/RNA binding protein 1 senses mitochondrial DNA to induce receptor-interacting protein kinase-3/mixed lineage kinase domain-like-driven necroptosis in developmental sevoflurane neurotoxicity. Neuroscience. 2022;507:99–111.
Song S, Tan J, Miao Y, Sun Z, Zhang Q. Intermittent-hypoxia-induced autophagy activation through the ER-stress-related PERK/eIF2α/ATF4 pathway is a protective response to pancreatic β-cell apoptosis. Cell Physiol Biochem. 2018;51:2955–71.
Shi Z, Xu L, Xie H, Ouyang R, Ke Y, Zhou R, et al. Attenuation of intermittent hypoxia-induced apoptosis and fibrosis in pulmonary tissues via suppression of ER stress activation. BMC Pulm Med. 2020;20:92.
Guan L, Ge R, Ma S. Newsights of endoplasmic reticulum in hypoxia. Biomed Pharmacother. 2024;175:116812.
Zhao Q, Zhang X, Zhang J, Zhang Y, Jia L, Guo S, et al. Reduction of D2 receptors on microglia leads to ZBP1-mediated PANoptosis of mPFC in Parkinson’s disease depression mice. Int Immunopharmacol. 2025;158:114809.
Deepa SS, Thadathil N, Corral J, Mohammed S, Pham S, Rose H, et al. MLKL overexpression leads to Ca(2+) and metabolic dyshomeostasis in a neuronal cell model. Cell Calcium. 2024;119:102854.
Wu Q, Qi S, Kang Z, Bai X, Li Z, Cheng J, et al. PANoptosis in sepsis: a central role and emerging therapeutic target. J Inflamm Res. 2025;18:6245–61.
Ghafouri-Fard S, Shoorei H, Poornajaf Y, Hussen BM, Hajiesmaeili Y, Abak A, et al. NLRP3: role in ischemia/reperfusion injuries. Front Immunol. 2022;ume 13:2022.
Liu R, Cao H, Zhang S, Cai M, Zou T, Wang G, et al. ZBP1-mediated apoptosis and inflammation exacerbate steatotic liver ischemia/reperfusion injury. J Clin Invest. 2024;134:e180451.
Zhai X, Wang W, Sun S, Han Y, Li J, Cao S, et al. 4-Hydroxy-2-nonenal promotes cardiomyocyte necroptosis via stabilizing receptor-interacting serine/threonine-protein kinase 1. Front Cell Dev Biol. 2021;ume 9:2021.
Zhan Q, Jeon J, Li Y, Huang Y, Xiong J, Wang Q, et al. CAMK2/CaMKII activates MLKL in short-term starvation to facilitate autophagic flux. Autophagy. 2022;18:726–44.
Li H, Yang D-H, Zhang Y, Zheng F, Gao F, Sun J, et al. Geniposide suppresses NLRP3 inflammasome-mediated pyroptosis via the AMPK signaling pathway to mitigate myocardial ischemia/reperfusion injury. Chin Med. 2022;17:73.
Kang P, Wang J, Fang D, Fang T, Yu Y, Zhang W, et al. Activation of ALDH2 attenuates high glucose induced rat cardiomyocyte fibrosis and necroptosis. Free Radic Biol Med. 2020;146:198–210.
Guo F, Han X, You Y, Xu S-j, Zhang Y-h, Chen Y-y, et al. Hydroxysafflor yellow A inhibits pyroptosis and protecting HUVECs from OGD/R via NLRP3/Caspase-1/GSDMD pathway. Chin J Integr Med. 2024;30:1027–34.
Li X, Gong W, Wang H, Li T, Attri KS, Lewis RE, et al. O-GlcNAc transferase suppresses inflammation and necroptosis by targeting receptor-interacting serine/threonine-protein kinase 3. Immunity. 2019;50:576–90.e6.
Xu R, Zhu Y, Jia J, Li WX, Lu Y. RIPK1/RIPK3-mediated necroptosis is involved in sevoflurane-induced neonatal neurotoxicity in the rat hippocampus. Cell Mol Neurobiol. 2022;42:2235–44.
Meng H, Wu G, Zhao X, Wang A, Li D, Tong Y, et al. Discovery of a cooperative mode of inhibiting RIPK1 kinase. Cell Discov. 2021;7:41.
Diz-Chaves Y, Mastoor Z, Spuch C, Gonzalez-Matias LC, Mallo F. Anti-inflammatory effects of GLP-1 receptor activation in the brain in neurodegenerative diseases. Int J Mol Sci. 2022;23:9583.
Lu ZH, Tang Y, Chen H, Liu F, Liu M, Fu L, et al. Identification and functional analysis of PANoptosis-associated genes in the progression from sepsis to ARDS. Immun Inflamm Dis. 2025;13:e70136.
Ye Q, Wang H, Chen Y, Zheng Y, Du Y, Ma C, et al. PANoptosis-like death in acute-on-chronic liver failure injury. Sci Rep. 2024;14:392.
Degterev A, Ofengeim D, Yuan J. Targeting RIPK1 for the treatment of human diseases. Proc Natl Acad Sci USA. 2019;116:9714–22.
Ju E, Park KA, Shen H-M, Hur GM. The resurrection of RIP kinase 1 as an early cell death checkpoint regulator—a potential target for therapy in the necroptosis era. Exp Mol Med. 2022;54:1401–11.
Hincelin-Mery A, Nicolas X, Cantalloube C, Pomponio R, Lewanczyk P, Benamor M, et al. Safety, pharmacokinetics, and target engagement of a brain penetrant RIPK1 inhibitor, SAR443820 (DNL788), in healthy adult participants. Clin Transl Sci. 2024;17:e13690.
Weisel K, Scott N, Berger S, Wang S, Brown K, Powell M, et al. A randomised, placebo-controlled study of RIPK1 inhibitor GSK2982772 in patients with active ulcerative colitis. BMJ Open Gastroenterol. 2021;8:e000680.
Wegner KW, Saleh D, Degterev A. Complex pathologic roles of RIPK1 and RIPK3: moving beyond necroptosis. Trends Pharm Sci. 2017;38:202–25.
Wang Y, Chai C, Lin W, Cao J, Li Z, Jin Y, et al. Oxidative stress-mediated PANoptosis and ferroptosis: exploration of multimodal cell death triggered by an AIE-active nano-photosensitizer via photodynamic therapy. Theranostics. 2025;15:6665–85.
Endale HT, Tesfaye W, Mengstie TA. ROS induced lipid peroxidation and their role in ferroptosis. Front Cell Dev Biol. 2023;ume 11:2023.
Park HH, Park SY, Mah S, Park JH, Hong SS, Hong S, et al. HS-1371, a novel kinase inhibitor of RIP3-mediated necroptosis. Exp Mol Med. 2018;50:1–15.
Mandal P, Berger SB, Pillay S, Moriwaki K, Huang C, Guo H, et al. RIP3 induces apoptosis independent of pronecrotic kinase activity. Mol Cell. 2014;56:481–95.
Petrie EJ, Sandow JJ, Jacobsen AV, Smith BJ, Griffin MDW, Lucet IS, et al. Conformational switching of the pseudokinase domain promotes human MLKL tetramerization and cell death by necroptosis. Nat Commun. 2018;9:2422.
Yuan F, Zhang Y, Zhu X, Hu H, Nan N, Wang H. GW806742X can induce mouse MLKL activation by directly promoting MLKL kinase like domain dimerization. Exp Cell Res. 2025;448:114539.
Barreyro FJ, Holod S, Finocchietto PV, Camino AM, Aquino JB, Avagnina A, et al. The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis. Liver Int. 2015;35:953–66.
Amand M, Adams P, Schober R, Iserentant G, Servais JY, Moutschen M, et al. The anti-caspase 1 inhibitor VX-765 reduces immune activation, CD4(+) T cell depletion, viral load, and total HIV-1 DNA in HIV-1 infected humanized mice. Elife. 2023;12:e83207.
Zhang W, Zhu C, Liao Y, Zhou M, Xu W, Zou Z. Caspase-8 in inflammatory diseases: a potential therapeutic target. Cell Mol Biol Lett. 2024;29:130.
Coll RC, Hill JR, Day CJ, Zamoshnikova A, Boucher D, Massey NL, et al. MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition. Nat Chem Biol. 2019;15:556–9.
Marchetti C, Swartzwelter B, Koenders MI, Dinarello CA, Joosten LA. OP0090 The human safe NLRP3 inflammasome inhibitor OLT1177 suppresses joint inflammation in murine models of experimental arthritis. Ann Rheum Dis. 2017;76:89.
Aglietti RA, Estevez A, Gupta A, Ramirez MG, Liu PS, Kayagaki N, et al. GsdmD p30 elicited by caspase-11 during pyroptosis forms pores in membranes. Proc Natl Acad Sci USA. 2016;113:7858–63.
Hu JJ, Liu X, Xia S, Zhang Z, Zhang Y, Zhao J, et al. FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation. Nat Immunol. 2020;21:736–45.
Majkutewicz I. Dimethyl fumarate: a review of preclinical efficacy in models of neurodegenerative diseases. Eur J Pharmacol. 2022;926:175025.
Yang W, Tao K, Wang Y, Huang Y, Duan C, Wang T, et al. Necrosulfonamide ameliorates intestinal inflammation via inhibiting GSDMD-medicated pyroptosis and MLKL-mediated necroptosis. Biochem Pharmacol. 2022;206:115338.
Chakraborty A, Tannenbaum S, Rordorf C, Lowe PJ, Floch D, Gram H, et al. Pharmacokinetic and pharmacodynamic properties of canakinumab, a human anti-interleukin-1beta monoclonal antibody. Clin Pharmacokinet. 2012;51:e1–18.
Dinarello CA, Simon A, van der Meer JW. Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat Rev Drug Discov. 2012;11:633–52.
Wong M, Ziring D, Korin Y, Desai S, Kim S, Lin J, et al. TNFalpha blockade in human diseases: mechanisms and future directions. Clin Immunol. 2008;126:121–36.
Zender L, Hutker S, Liedtke C, Tillmann HL, Zender S, Mundt B, et al. Caspase 8 small interfering RNA prevents acute liver failure in mice. Proc Natl Acad Sci USA. 2003;100:7797–802.
Kim D-Y, Leem Y-H, Park J-S, Kim S-E, Choi Y-H, Kang JL, et al. Anti-inflammatory mechanism of the MLKL inhibitor necrosulfonamide in LPS- or poly(I:C)-induced neuroinflammation and necroptosis. Biochem Pharmacol. 2025;239:117021.
Klein R, Onyuru J, Centa JL, Viera EM, Duelli FJ, Putnam CD, et al. Modulating NLRP3 splicing with antisense oligonucleotides to control pathological inflammation. bioRxiv. 2025.
Sun X, Setrerrahmane S, Li C, Hu J, Xu H. Nucleic acid drugs: recent progress and future perspectives. Signal Transduct Target Ther. 2024;9:316.
Wang F, Liang Q, Ma Y, Sun M, Li T, Lin L, et al. Silica nanoparticles induce pyroptosis and cardiac hypertrophy via ROS/NLRP3/Caspase-1 pathway. Free Radic Biol Med. 2022;182:171–81.
Meng Z, Lu M. RNA interference-induced innate immunity, off-target effect, or immune adjuvant?. Front Immunol. 2017;8:331.
Peterson LW, Philip NH, DeLaney A, Wynosky-Dolfi MA, Asklof K, Gray F, et al. RIPK1-dependent apoptosis bypasses pathogen blockade of innate signaling to promote immune defense. J Exp Med. 2017;214:3171–82.
Yuan J, Najafov A, Py BF. Roles of caspases in necrotic cell death. Cell. 2016;167:1693–704.
Wang L, Zhu Y, Zhang L, Guo L, Wang X, Pan Z, et al. Mechanisms of PANoptosis and relevant small-molecule compounds for fighting diseases. Cell Death Dis. 2023;14:851.
Yoon S-H, Kim C, Lee E, Lee C, Lee K-S, Lee J, et al. Microglial NLRP3-gasdermin D activation impairs blood-brain barrier integrity through interleukin-1β-independent neutrophil chemotaxis upon peripheral inflammation in mice. Nat Commun. 2025;16:699.
Ofengeim D, Ito Y, Najafov A, Zhang Y, Shan B, DeWitt JP, et al. Activation of necroptosis in multiple sclerosis. Cell Rep. 2015;10:1836–49.
Rathinam VAK, Jiang Z, Waggoner SN, Sharma S, Cole LE, Waggoner L, et al. The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat Immunol. 2010;11:395–402.
Boyd DF, Jordan SV, Balachandran S. ZBP1-driven cell death in severe influenza. Trends Microbiol. 2025;33:521–32.
Xu W, Huang Y, Zhou R. NLRP3 inflammasome in neuroinflammation and central nervous system diseases. Cell Mol Immunol. 2025;22:341–55.
Lule S, Wu L, McAllister LM, Edmiston WJ, Chung JY, Levy E, et al. Genetic inhibition of receptor interacting protein kinase-1 reduces cell death and improves functional outcome after intracerebral hemorrhage in mice. Stroke. 2017;48:2549–56.
He S, Huang S, Shen Z. Biomarkers for the detection of necroptosis. Cell Mol Life Sci. 2016;73:2177–81.
Jiang A, Zhang H, Jia X, Zhao H, Zhao H, Lu Z. Identification of PANoptosis-related genes as biomarkers in ischemic stroke. Front Neurol. 2025;ume 16:2025.
Wang N, Zhang L, Xu Z, Xu Q, Lu Y, Niu P, et al. Unveiling PANoptosis in acute kidney injury: an integrative multi-dimensional approach to identify key biomarkers. J Inflamm Res. 2025;18:8735–54.
Banati RB, Goerres GW, Myers R, Gunn RN, Turkheimer FE, Kreutzberg GW, et al. [11C](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen’s encephalitis. Neurology. 1999;53:2199–203.
Mo B, Ding Y, Ji Q. NLRP3 inflammasome in cardiovascular diseases: an update. Front Immunol. 2025;16:1550226.
Upadhyay S, Upmanyu K, Gabr MT. Designing immunity with cytokines: a logic-based framework for programmable CAR therapies. Cytokine Growth Factor Rev. 2025;86:40–55.